Skip to content

New Owner

McKesson - Vantage Oncology

McKesson acquires Vantage Oncology

Announced: April 04, 2016

Type:           Acquisition
Disposition: Separate Entity
Terms:         Cash
Status:         Complete

Amount:       $ 525,000,000

Acquisition News

Add News

Date Title
Apr 04, 2016 Business Wire - McKesson Completes the Acquisitions of Vantage Oncology and Biologics
McKesson Completes the Acquisitions of Vantage Oncology and Biologics

McKesson Other Acquisitions

Add Acquisition

Date Acquired Amount
Nov 06, 2017
RxCrossroads
Undisclosed amount
Jan 25, 2017
CoverMyMeds
$ 1,100,000,000
Jul 12, 2016
HealthQx
Undisclosed amount
Mar 02, 2016
Rexall
$ 2,100,000,000
Feb 25, 2016
Biologics
$ 1,200,000,000
View more acquisitions »